Although the pair of ridesharing tech companies are the most talked about public offerings of 2019, with Uber till waiting to officially go public and Lyft already hitting 22% of increase with the closing of the first public trading session as it started out at the price of 72$ per share, there are many IPOs waiting to hit the markets.

Silk Road Medical is one of such companies, and also a prominent company in the sector of medical devices showcasing growth potential and reporting increasing revenue from year to year, while the industry of medical devices is in the surge as well as the healthcare sector due to the constant demand.

What You Need to Know Before Silk Road Medical Goes Public with the Upcoming IPO in 2019

Silk Road Medical company is operating in the sector of medical devices, that way helping the reduction and mitigation of risk factors that normally cause stroke. They use innovative medical techniques, using approach known as trans carotid artery revascularization, which is a minimally invasive and maximally innovative endovascular technique.

The company has Medicare coverage and is compliant with FDA, having been received all required approvals, while the revenue of the company reported for the period between 2017 and 2018 exceeded 34.6 million dollars.

That might not sound as flashy as billions in revenue, but it is important to note that the company reported increases by 142% in revenues in a single year for the mentioned period.

Based on the fact that there are 427,000 new diagnosis in 2018 set for carotid artery disease with 4.3 million people who suffer from this condition in the US alone, the company estimates for market opportunity stand at 2.6 billion dollars.

Nasdaq already approved Silk Road Medical for listing under the thicker SILK, while the company is set to issue 4.7 million A class shares at the starting price between 15$ and 17$.